EP4 receptor agonist, compositions and methods thereof
USRE42562E1 · kind E1 · reissue
0Cited by
12References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2007 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Apr 26, 2027 |
Classification
- Technology area (CPC —)General
Abstract
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.